choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Micardis

Micardis Newsletter
  • Analysis: Is the Trump Administration Eroding Trust in the FDA? 16 Oct 2020 11:27 GMT

    … known as antibodies. Regeneron Pharmaceuticals, the developer, is … trials of plasma and Regeneron’s experimental antibody treatment … clinical trial to prove that the hypertension drug telmisartan (Micardis) … unsafe and ineffective medicines.” The FDA is charged …

  • Drugs for heartburn, gout and depression now being tested as coronavirus treatments 02 May 2020 15:10 GMT

    … care. Regeneron Pharmaceuticals Inc. will test its drug sarilumab (Kevzara) … return to normal after treatment with tocilizumab, 15 … trials, Montefiore Medical Center in New York will test the drug … (Luvox) is an antidepressant used mainly to treat obsessive …

  • How R&D spends make Alembic Pharmaceuticals a good buy 09 May 2020 13:14 GMT

    … (CVS), Celebrex (Pain) and Micardis (CVS). However, its US … 183 ANDAs (abbreviated new drug application) with the USFDA, … (National List of Essential Medicines) expansion and higher raw … ’s overall API (active pharmaceutical ingredients) segment contributes 13 …

  • Company news: Glenmark Pharmaceuticals 05 Mar 2019 17:43 GMT

    Glenmark Pharmaceuticals on Tuesday said it has … version of Boehringer Ingelheim Pharmaceuticals Inc’s Micardis HCT tablets. Quoting IQVIA … January 2019, Glenmark said the Micardis HCT tablets market achieved annual …

  • Discovery of colon cancer pathway could lead to new targeted treatments 27 Feb 2019 04:41 GMT

    … some FDA-approved drugs inhibit CYP monooxygenases, including Micardis, a blood pressure medication, and … cholesterol. “That suggests that these drugs could be repurposed for preventing …

  • Algerian, German firms ink 22.86-mln-USD deal for local production of medicines 15 Jan 2019 13:39 GMT

    … includes manufacture of blood pressure medicine MICARDIS Plus and type 2 diabetes … JARDIANCE medication. The JARDIANCE medication will be produced from … Ingelheim. But the manufacture of MICARDIS Plus is due in April …

  • Louisiana benefits from settlement with pharmaceutical company 04 Jan 2018 04:59 GMT

    … . The company also stated that Micardis protected patients from early morning … benefits and risks of prescription drugs, pharmaceutical companies must relay correct information … and claimed the medications were essential for the treatment of COPD. The …

  • West Virginia to Get $153K in Drugmaker Settlement 25 Jan 2018 06:54 GMT

    … million settlement with Boehringer Ingelheim Pharmaceuticals Inc. The settlement resolves … misrepresented the effectiveness of four drugs in treating or managing … chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent …

  • Idaho to receive nearly $151,000 in settlement with pharmaceutical company 01 Jan 2018 22:13 GMT

    … million settlement with Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). … its promotion of four prescription drugs: Micardis®, Aggrenox®, Atrovent®, and … a first-line treatment for bronchospasms associated … four drugs are referred to BIPI’s Medical Division

  • Beshear details settlement with pharmaceutical company 27 Dec 2017 00:18 GMT

    … a Connecticut-based pharmaceutical company for improperly promoting its drugs to Kentuckians … that claim; · Misrepresented that Micardis® protected patients from early morning … used as a first-line treatment for bronchospasms associated with chronic …

Satisfied with the content?

Continue to create your account.